↓ Skip to main content

Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy

Overview of attention for article published in Frontiers in immunology, October 2023
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy
Published in
Frontiers in immunology, October 2023
DOI 10.3389/fimmu.2023.1261070
Pubmed ID
Authors

Hweixian Leong Penny, Kelly Hainline, Nathaniel Theoharis, Bin Wu, Christian Brandl, Christian Webhofer, Mason McComb, Sabine Wittemer-Rump, Gökben Koca, Sabine Stienen, Ralf C. Bargou, Horst-Dieter Hummel, Wolfgang Loidl, Carsten Grüllich, Tobias Eggert, Ben Tran, Daniel T. Mytych

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 36%
Unspecified 1 9%
Student > Ph. D. Student 1 9%
Other 1 9%
Unknown 4 36%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 18%
Biochemistry, Genetics and Molecular Biology 2 18%
Unspecified 1 9%
Immunology and Microbiology 1 9%
Engineering 1 9%
Other 0 0%
Unknown 4 36%